Online first
Clinical vignette
Published online: 2024-07-05
Zero-contrast TAVI: A novel alternative for a difficult patient population
Pubmed: 38973442
Abstract
Not available
References
- Mack MJ, Leon MB, Smith CR, et al. PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015; 385(9986): 2477–2484.
- Galper BZ, Chinnakondepalli KM, Wang K, et al. PARTNER Investigators. Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the PARTNER 3 Trial. Circulation. 2023; 147(21): 1594–1605.
- Carroll JD, Mack MJ, Vemulapalli S, et al. STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol. 2020; 76(21): 2492–2516.
- Jäckel M, Keller S, Prager EP, et al. The impact of transcatheter aortic valve implantation planning and procedure on acute and chronic renal failure. Cardiol J. 2023; 30(2): 247–255.
- Freire AF, Nicz PF, Ribeiro HB, et al. Non-contrast transcatheter aortic valve implantation for patients with aortic stenosis and chronic kidney disease: a pilot study. Front Cardiovasc Med. 2023; 10: 1175600.
